Cornelis J.A. Punt
0000-0003-0846-1445
Publication & Citation Trends
Publications
0 total
Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
Cited by 0
Semantic Scholar
Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.
Cited by 1
Semantic Scholar
686P Upfront S-1-based treatment in gastrointestinal cancer patients with severe cardiac comorbidity OA
Cited by 0
Semantic Scholar
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial.
Cited by 0
Semantic Scholar
693eP Switch from 5FU/capecitabine- to S-1-based treatment for handfoot syndrome (HFS) or cardiovascular toxicity (CVT) in cancer patients (pts) carrying DPYD variants OA
Cited by 0
Semantic Scholar
Time of Detection of Liver Metastases and Survival in Patients With Colorectal Cancer OA
Cited by 2
Semantic Scholar
Trifluridine-tipiracil versus radioembolization for patients with refractory colorectal liver metastases: A real-world data analysis. OA
Cited by 0
Semantic Scholar
Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial. OA
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(307)
Immunotherapy and Immune Responses
(127)
Genetic factors in colorectal cancer
(113)
Cancer Genomics and Diagnostics
(102)
Colorectal Cancer Surgical Treatments
(93)
Affiliations
AstraZeneca (United Kingdom)
University of Pisa
European Organisation for Research and Treatment of Cancer
Fox Chase Cancer Center
University College Hospital
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.